Literature DB >> 18635948

Mucolipidosis type IV: the importance of functional lysosomes for efficient autophagy.

Silvia Vergarajauregui1, Rosa Puertollano.   

Abstract

Mucolipidosis IV (MLIV) is a lysosomal storage disorder characterized by severe neurological and ophthalmologic abnormalities. In contrast with most lysosomal storage disorders, which are attributed to the absence of specific lysosomal hydrolases, accumulation of material in MLIV results from defects in membrane transport along the late endocytic pathway. Mutations in MCOLN1 are the cause of MLIV; however, how the lack of MCOLN1 function ultimately leads to neurodegeneration remains largely unknown. We found that MCOLN1 is required for efficient fusion of both late endosomes and autophagosomes with lysosomes. Impaired autophagosome degradation results in accumulation of autophagosomes in MLIV fibroblasts. In addition, we found increased levels and aggregation of p62, suggesting that abnormal accumulation of ubiquitinated protein inclusions may contribute to the neurodegenerative phenotype observed in MLIV patients. These findings corroborate recent evidence indicating that defects in autophagy may be a common feature of many neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635948      PMCID: PMC2625312          DOI: 10.4161/auto.6567

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  30 in total

Review 1.  The role of macroautophagy in the ageing process, anti-ageing intervention and age-associated diseases.

Authors:  E Bergamini; G Cavallini; A Donati; Z Gori
Journal:  Int J Biochem Cell Biol       Date:  2004-12       Impact factor: 5.085

2.  Autophagy promotes MHC class II presentation of peptides from intracellular source proteins.

Authors:  Jörn Dengjel; Oliver Schoor; Rainer Fischer; Michael Reich; Marianne Kraus; Margret Müller; Katharina Kreymborg; Florian Altenberend; Jens Brandenburg; Hubert Kalbacher; Roland Brock; Christoph Driessen; Hans-Georg Rammensee; Stefan Stevanovic
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-13       Impact factor: 11.205

3.  Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.

Authors:  Gaia Skibinski; Nicholas J Parkinson; Jeremy M Brown; Lisa Chakrabarti; Sarah L Lloyd; Holger Hummerich; Jørgen E Nielsen; John R Hodges; Maria Grazia Spillantini; Tove Thusgaard; Sebastian Brandner; Arne Brun; Martin N Rossor; Anders Gade; Peter Johannsen; Sven Asger Sørensen; Susanne Gydesen; Elizabeth M C Fisher; John Collinge
Journal:  Nat Genet       Date:  2005-07-24       Impact factor: 38.330

4.  Mapping of the mucolipidosis type IV gene to chromosome 19p and definition of founder haplotypes.

Authors:  S A Slaugenhaupt; J S Acierno; L A Helbling; C Bove; E Goldin; G Bach; R Schiffmann; J F Gusella
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

Review 5.  Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease.

Authors:  Kevin Talbot; Olaf Ansorge
Journal:  Hum Mol Genet       Date:  2006-10-15       Impact factor: 6.150

6.  Mucolipidosis IV consists of one complementation group.

Authors:  E Goldin; A Cooney; C R Kaneski; R O Brady; R Schiffmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

7.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.

Authors:  Brinda Ravikumar; Coralie Vacher; Zdenek Berger; Janet E Davies; Shouqing Luo; Lourdes G Oroz; Francesco Scaravilli; Douglas F Easton; Rainer Duden; Cahir J O'Kane; David C Rubinsztein
Journal:  Nat Genet       Date:  2004-05-16       Impact factor: 38.330

8.  Mucolipidosis type IV: clinical spectrum and natural history.

Authors:  N Amir; J Zlotogora; G Bach
Journal:  Pediatrics       Date:  1987-06       Impact factor: 7.124

9.  Ocular abnormalities in mucolipidosis IV.

Authors:  K G Riedel; J Zwaan; K R Kenyon; E H Kolodny; L Hanninen; D M Albert
Journal:  Am J Ophthalmol       Date:  1985-02-15       Impact factor: 5.258

10.  ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B).

Authors:  N Parkinson; P G Ince; M O Smith; R Highley; G Skibinski; P M Andersen; K E Morrison; H S Pall; O Hardiman; J Collinge; P J Shaw; E M C Fisher
Journal:  Neurology       Date:  2006-06-28       Impact factor: 9.910

View more
  15 in total

Review 1.  Transient receptor potential (TRP) channels: a clinical perspective.

Authors:  Yosuke Kaneko; Arpad Szallasi
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 2.  The intersection of lysosomal and endoplasmic reticulum calcium with autophagy defects in lysosomal diseases.

Authors:  Elaine A Liu; Andrew P Lieberman
Journal:  Neurosci Lett       Date:  2018-04-25       Impact factor: 3.046

Review 3.  Transient receptor potential channelopathies.

Authors:  Bernd Nilius; Grzegorz Owsianik
Journal:  Pflugers Arch       Date:  2010-02-04       Impact factor: 3.657

Review 4.  Regulation of Transporters and Channels by Membrane-Trafficking Complexes in Epithelial Cells.

Authors:  Curtis T Okamoto
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-11-01       Impact factor: 10.005

5.  Association of luteal cell degeneration and progesterone deficiency with lysosomal storage disorder mucolipidosis type IV in Mcoln1-/- mouse model†.

Authors:  Zidao Wang; Ahmed E El Zowalaty; Yuehuan Li; Christian L Andersen; Xiaoqin Ye
Journal:  Biol Reprod       Date:  2019-10-25       Impact factor: 4.285

6.  Diminished MTORC1-Dependent JNK Activation Underlies the Neurodevelopmental Defects Associated with Lysosomal Dysfunction.

Authors:  Ching-On Wong; Michela Palmieri; Jiaxing Li; Dmitry Akhmedov; Yufang Chao; Geoffrey T Broadhead; Michael X Zhu; Rebecca Berdeaux; Catherine A Collins; Marco Sardiello; Kartik Venkatachalam
Journal:  Cell Rep       Date:  2015-09-17       Impact factor: 9.423

7.  Roles of CUP-5, the Caenorhabditis elegans orthologue of human TRPML1, in lysosome and gut granule biogenesis.

Authors:  Erin M Campbell; Hanna Fares
Journal:  BMC Cell Biol       Date:  2010-06-11       Impact factor: 4.241

8.  Identification of the penta-EF-hand protein ALG-2 as a Ca2+-dependent interactor of mucolipin-1.

Authors:  Silvia Vergarajauregui; Jose A Martina; Rosa Puertollano
Journal:  J Biol Chem       Date:  2009-10-28       Impact factor: 5.157

Review 9.  Role of lysosomes in physiological activities, diseases, and therapy.

Authors:  Ziqi Zhang; Pengfei Yue; Tianqi Lu; Yang Wang; Yuquan Wei; Xiawei Wei
Journal:  J Hematol Oncol       Date:  2021-05-14       Impact factor: 17.388

10.  Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI.

Authors:  Alessandra Tessitore; Marinella Pirozzi; Alberto Auricchio
Journal:  Pathogenetics       Date:  2009-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.